China medical device/In-Vitro Diagnostic (IVD) regulations are ever-changing with increasing complexity. Our integrated and seasoned team can help you develop a customized RA strategy and deal with complex regulatory challenges. Our team excels in three critical areas: technical, clinical, and regulatory.
China RA Strategy & Consulting
By helping 250+ of manufacturers through this process, China Med Device team has established best practices that encourage collaboration, reduce snafus, and expedite registration speed.
Identify NMPA Classification and Registration Composition Units
Design Phase Consultation
Estimate Registration Costs & Timeline
Provide Reference NMPA Regulations and Materials
We also provide multiple information channels for NMPA updates such as monthly newsletters, webinars, white papers, etc. Please click here to opt-in.